<DOC>
	<DOCNO>NCT00001231</DOCNO>
	<brief_summary>The purpose study investigate mood behavior change time period surround include menopause . This observational study ; volunteer participate receive new experimental therapy . Controversy exist regard relationship estrogen progesterone ( gonadal steroid ) change midlife-onset depression . This study examine role gonadal steroid perimenopausal mood behavioral disorder . Perimenopausal woman depression symptom control group healthy perimenopausal volunteer compare identify correlate occurrence depression . Participants depressive symptom may also participate companion study test antidepressant efficacy phytoestrogens selective estrogen receptor modulators ( SERMS ) . A group young pre-perimenopausal woman normal menstrual cycle functioning follow menopause effort confirm association depression onset change reproductive endocrine functioning .</brief_summary>
	<brief_title>Perimenopause-Related Mood Behavioral Disorders</brief_title>
	<detailed_description>Controversy exist regard relevance change gonadal steroid midlife onset depression . The purpose protocol allow careful screening patient healthy volunteer participation research protocol examine role gonadal steroid depression occur perimenopause collection natural history data . Women protocol undergo evaluation may include : psychiatric diagnostic interview ; rating scale ; medical history ; physical exam ; blood urine laboratory evaluation ; request medical record . The data collect may also link data perimenopausal depression protocol ( e.g. , DNA , psychophysiology test , treatment study , etc . ) purpose well understanding diagnosis , pathophysiology , treatment response woman depression perimenopause . Upon conclusion screen process , participant either offer entry research protocol sign appropriate inform consent , consider appropriate participation research refer back community . The second purpose protocol permit identification premenopausal woman follow longitudinally menopause transition effort confirm association depression onset change reproductive endocrine function . This protocol , , serve screen evaluation protocol recruit subject characterized standard measure protocol offer participation relate study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<criteria>INCLUSION CRITERIA : Perimenopausal Subjects : History within last one year least one month perimenopauserelated mood behavioral disturbance least moderate severity , disturbance distinct appearance associate notable degree functional impairment ; Age 4060 ; History onset menstrual irregularity past six month great one year amenorrhea ( i.e. , postmenopausal ) ; Biological evidence deterioration normal ovarian activity , specifically , plasma FSH level persistently elevate ( &gt; 14IU/L ) ( recommend Stages Reproductive Aging Workshop criterion ( 106 ) ) draw two week interval period eight week ; No prior estrogen replacement therapy treatment perimenopausal physical emotional symptom within last six month ; In good medical health ; Subjects must competent comprehend purpose screen process provide write informed consent willing participate NIMH IRB approve research protocol . A control group agematched perimenopausal woman meet patient selection criterion exception presence mood behavioral disorder also seek . Premenopausal woman woman meet follow inclusion criterion longitudinal study participant : Regular menstrual cycle function ( 2134 day ) ; Absence current mood behavioral disturbance determine structure diagnostic interview ; Plasma gonadotropin level preperimenopausal range ( &lt; 14 IU/L ) ; In good medical health ; Medication free . EXCLUSION CRITERIA : Primary general medical illness ( i.e. , appear cause mood disorder ) ; Current antidepressant therapy ( since screen protocol subsequent treatment study participant must untreated ) . Antidepressants withhold participant need want ; Current alcohol substance abuse dependence ( exclude nicotine ) sufficient magnitude require independent , concurrent treatment intervention ( e.g. , antabuse opiate treatment , include selfhelp group ) ; Pregnant lactate woman ; Subjects unable provide inform consent . Additional Exclusion criterion Dex/CRH protocol : Pregnant plan become pregnant within next 6 month , Sexually active willing use barrier method birth control diaphragm condom spermicide , Heart lung disease , chest pain , frequent shortness breath , trouble breathe lie flat serious heart disease ( example , high blood pressure high cholesterol level ) , Current medical illness , fever , chronic medical condition , Taking medication regularly , able stop take overthecounter medication acetaminophen ( Tylenol ) , completely one week study testing .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 4, 2016</verification_date>
	<keyword>Mood</keyword>
	<keyword>Behavior</keyword>
	<keyword>Cognition</keyword>
	<keyword>Climacteric</keyword>
	<keyword>Menopause</keyword>
	<keyword>Perimenopause</keyword>
	<keyword>Midlife</keyword>
	<keyword>Depression</keyword>
</DOC>